MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/iju.70433

Медицинская библиотека · International journal of urology : official journal of the Japanese Urological Association · 2026

Active Surveillance for Localized Prostate Cancer: A Retrospective Single-Center Study.

Sugino Akihiko, Miyazawa Yoshiyuki, Nakazawa Shun, Tsuji Yusuke, Fujizuka Yuji, Arai Seiji, Sekine Yoshitaka, Nomura Masashi, Koike Hidekazu, Matsui Hiroshi, Suzuki Kazuhiro

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Active surveillance (AS) offers a strategy to limit unnecessary treatment of prostate cancer while maintaining oncologic safety, yet its adoption in Japan remains limited. To provide Japan-specific evidence, we evaluated the clinical outcomes of patients undergoing AS at our institution.

METHODS

We retrospectively reviewed 86 patients who selected AS between 2012 and 2024. Eligibility criteria included ≤ cT2a disease, prostate-specific antigen (PSA) level of ≤ 10 ng/mL, Gleason score (GS) of 3 + 3, and 2 or fewer positive cores, with selected inclusion of GS 3 + 4 or 4 + 3 based on patient preference. AS discontinuation was based on clinical or pathological progression or patient preference. This study was approved by the institutional review board of Gunma University (approval no. IRB2025-033, 2310).

RESULTS

The mean observation period was 48 months. No prostate cancer-specific deaths occurred. AS persistence rates were 89% at 1 year, 55% at 5 years, and 27% at 10 years. Older age (≥ 75 years) was associated with longer AS persistence (p = 0.021). Overall, 69% of patients underwent repeat biopsy, most commonly at 1 year. Pathological upgrading occurred in 35% at the first and second repeat biopsies and in 20% at the third. Acceptance of the 1-year repeat biopsy increased from 46% in the early period (2012-2016) to 64% in the later period (2017-2024).

CONCLUSIONS

AS demonstrated favorable long-term safety and durability. Improving adherence to repeat biopsy protocols may further enhance AS management in Japan. REGISTRY AND REGISTRATION NO.

OF THE STUDY/TRIAL: N/A.

Для цитирования: Sugino Akihiko, Miyazawa Yoshiyuki, Nakazawa Shun, Tsuji Yusuke, Fujizuka Yuji, Arai Seiji, Sekine Yoshitaka, Nomura Masashi, Koike Hidekazu, Matsui Hiroshi, Suzuki Kazuhiro. Active Surveillance for Localized Prostate Cancer: A Retrospective Single-Center Study.. International journal of urology : official journal of the Japanese Urological Association. 2026. DOI: 10.1111/iju.70433.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.